Elena Verzoni

4PUBLICATIONS

14CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Apr 05, 2023

Tailoring treatment with cabozantinib or pazopanib in patients with metastatic renal cell carcinoma: does it affect outcome?

Matilde Corianò, Diana Giannarelli, Giulia Scartabellati

|Oct 24, 2022

Optimal Choice of Adjuvant Treatment for Renal Cell Carcinoma Following Nephrectomy.

Achille Bottiglieri, Pierangela Sepe, Marco Stellato

|Nov 05, 2021

Cabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21).

Alessia Mennitto, Emma Zattarin, Massimo Di Maio

|Jan 21, 2021

Radical metastasectomy followed by sorafenib versus observation in patients withclear cell renal cell carcinoma: extended follow -up of efficacy results from the randomized phase II RESORT trial.

A Mennitto, E Verzoni, F Cognetti

Pageof 1

Frequent Collaborators

2 joint publications

Alessia Mennitto

2 joint publications

Melanie Claps

2 joint publications

Valentina Guadalupi

2 joint publications

Filippo G De Braud

2 joint publications

Giuseppe Procopio

2 joint publications

Sebastiano Buti

1 joint publications

R Miceli

1 joint publications

A Mosca

1 joint publications

F Morelli

1 joint publications

F Atzori

Frequent Collaborators

2 joint publications

Alessia Mennitto

2 joint publications

Melanie Claps

2 joint publications

Valentina Guadalupi

2 joint publications

Filippo G De Braud